This study is looking at ways to reduce cancer-related fatigue in people with metastatic cancers (cancers that have spread). It's testing if combining psychoeducational interventions (education, counseling, and self-managed therapies) with an open-label placebo (a pill you know is a placebo) works better than either approach alone. You could join if you are 18 or older, have advanced cancer, and have experienced fatigue for at least two weeks with a severity of 4 out of 10 or higher. The main goal is to see if the combination therapy reduces fatigue more effectively, as measured by a specific fatigue scale. The study aims to enroll 240 participants, but its current recruitment status is unclear.

Study design

This interventional study plans to enroll 240 participants. It compares three groups: psychoeducational intervention only, open-label placebo only, and a combination of both.

What's involved

Participants in the psychoeducational intervention groups will complete educational sessions. Those in placebo groups will take placebo capsules daily.

Compensation

Not stated in the trial record.

Follow-up

Adverse events will be monitored through study completion, which is an average of one year. Fatigue levels will also be assessed at 3 and 6 months after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.